Trials / Completed
CompletedNCT03371888
The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders
The Platelet -Rich Plasma in the Therapy of Temporomandibular Disorders
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Medical University of Silesia · Academic / Other
- Sex
- All
- Age
- 23 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
The Platelet-Rich Plasma intramuscular injections into the masseter and temporalis muscle were performed to reduce painful temporomandibular disorder symptoms,such as myalgia, myofascial pain and myofascial pain with referrals. Patients(n=120) were randomly divided into two groups: experimental(n=60) and control group(n=60). In controls injections with 0,9% NaCl were performed. Pain intensity was measured with NPRS (numeriic pain rating scale, 0= no pain, 11= the worst pain that one can imagine) before(0 day), during(10 day) and after(20 day) the therapy with PRP injections.
Detailed description
Patients(n=120) attending The Department of Temporomandibular Disorders and Orthodontics at the Silesian Medical University Poland, Zabrze were enrolled to the study and randomly divided into one of two groups: experimental and control group. Platelet-Rich Plasma(PRP) was prepared for each patient and an intramuscular injections of 0,5 ml PRP into 6 points at each side were performed in experimental group. A follow-up appointment was made after 10 and 20 days and in each visit an injection of PRP or 0,9% NaCl was performed. Pain intensity was measured in NPRS(numeric pain rating scale) and collected data data were analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Platelet-Rich Plasma intramuscular injections | A platelet-rich plasma intramuscular injections into the trigger points of painful muscles were performed. |
| BIOLOGICAL | Placebo Comparator: 0,9% NaCl intramuscular injections | A 0,9% NaCl intramuscular injections into the trigger points of painful muscles were performed. |
Timeline
- Start date
- 2017-12-07
- Primary completion
- 2018-12-15
- Completion
- 2019-01-01
- First posted
- 2017-12-13
- Last updated
- 2019-01-04
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03371888. Inclusion in this directory is not an endorsement.